Quidel_安诺伦(北京)生物科技有限公司

美国Quidel公司是一个上市公司，本着提高人类健康和幸福的目标，在全球各地开拓、销售快速检测诊断试剂的企业，致力于研发产品，领域涉及妊娠、传染病、肿瘤、自身免疫性疾病和骨质疏松症。 Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcaremanufacturer serving to enhance the health and well-being of people around theglobe through the development of diagnostic solutions that can lead to improvedpatient outcomes and provide economic benefits to the healthcare system. Quidelcommenced operations in 1979 and launched its first products in 1984. Sincethat time, Quidel has expanded its product base through internal developmentand acquisition with a focus on increasing its research and development effortsto accelerate the rate of new product introductions. Our core competencies andcapabilities include immunoassay development, automated manufacturing,monoclonal antibody characterization and development, and molecular assaydevelopment. Our current products fall generally into these categories: (1)lateral flow, where we are market leaders in infectious disease andreproductive health; (2) direct fluorescent antibodies (DFA), with expertise ininfectious disease and virology; (3) micro-titer production, with a focus onbone and complement pathway markets; (4) fluorescent immunoassay products(Sofia); and (5) molecular diagnostic products including the world’s firstFDA-clearedhandheld molecular device, AmpliVue. Additional molecular andSofia tests are currently in development or in clinical trials as part of arobust product pipeline. Whether at our headquartersin San Diego, California, at our research and manufacturing operations in Ohio,Massachusetts, or in Germany, or through our Commercial organization around theworld, Quidel is delivering a continuum of diagnostic solutions from advancedlateral-flow and direct fluorescent antibody to molecular diagnostic tests thatfurther improve the quality of healthcare. 产品列表： 安诺伦官方微信

微信扫描二维码，随时随地与小诺亲密接触，精彩活动，劲爆优惠，触手可得！